Efficacy of preoperative dexamethasone for postoperative nausea and vomiting after laparoscopic cholecystectomy: A large-scale, multicenter, randomized, double-blind, placebo-controlled trial in Japan

Masaki Wakasugi, Masayuki Tori, Junzo Shimizu, Yong Kook Kim, Takehiro Noda, Keizo Dono, Yutaka Takeda, Tameyoshi Yamamoto, Satoshi Oshima, Yoshikazu Morimoto, Tadafumi Asaoka, Hidetoshi Eguchi, Hiroaki Nagano, Masaki Mori, Yuichiro Doki

研究成果: Contribution to journalArticle

5 引用 (Scopus)

抜粋

Background To assess the efficacy of preoperative dexamethasone for postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy (LC) in Japan. Methods A total of 270 patients at eight hospitals were randomized to receive dexamethasone 8 mg (n = 136) or placebo (n = 134) intravenously before LC. The primary endpoint was the degree of PONV and antiemetic requirements within 24 h after LC. Secondary endpoints were postoperative complications, postoperative hospital stay, and cost of hospital stay. This study was registered: UMIN-CTR (UMIN000003841). Results Within 6 h after LC, 17% (23/136) of patients in the dexamethasone group versus 24% (32/134) in the placebo group reported nausea (P = 0.3), and 5% (7/136) versus 7% (10/134) reported vomiting (P = 0.2). Metoclopramide 10 mg was used 0.09 ± 0.31 versus 0.14 ± 0.35 times (P = 0.2). From 6 to 24 h, 10% (14/136) versus 13% (17/134) reported nausea (P = 0.5), and 5% (7/136) versus 5% (7/134) reported vomiting (P = 0.8). Metoclopramide was used 0.04 ± 0.19 versus 0.03 ± 0.17 times (P = 0.8). Postoperative complications and postoperative hospital stay did not differ significantly between the two groups, but the cost of hospital stay was slightly higher in the dexamethasone group (P < 0.05). Conclusions Routine use of preoperative dexamethasone for PONV after elective LC in Japan was not shown to have a clinical advantage. Highlight Wakasugi and colleagues set out to evaluate the prophylactic efficacy of preoperative dexamethasone for postoperative nausea and vomiting after elective laparoscopic cholecystectomy. Preoperative dexamethasone showed no clinical advantage, as it failed to significantly reduce the incidence of postoperative nausea and vomiting, while it increased the cost of hospital stay.

元の言語英語
ページ(範囲)802-809
ページ数8
ジャーナルJournal of Hepato-Biliary-Pancreatic Sciences
22
発行部数11
DOI
出版物ステータス出版済み - 11 2015

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント Efficacy of preoperative dexamethasone for postoperative nausea and vomiting after laparoscopic cholecystectomy: A large-scale, multicenter, randomized, double-blind, placebo-controlled trial in Japan' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Wakasugi, M., Tori, M., Shimizu, J., Kim, Y. K., Noda, T., Dono, K., Takeda, Y., Yamamoto, T., Oshima, S., Morimoto, Y., Asaoka, T., Eguchi, H., Nagano, H., Mori, M., & Doki, Y. (2015). Efficacy of preoperative dexamethasone for postoperative nausea and vomiting after laparoscopic cholecystectomy: A large-scale, multicenter, randomized, double-blind, placebo-controlled trial in Japan. Journal of Hepato-Biliary-Pancreatic Sciences, 22(11), 802-809. https://doi.org/10.1002/jhbp.285